20
Chemwerth Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
One of their notable products is BROENAC SODIUM (SESQUIHYDRATE), with a corresponding US DMF Number 24521.
Remarkably, this DMF maintains an Active status since its submission on May 20, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 17, 2013, and payment made on July 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II